The effect of acute and chronic diazepam treatment on stress-induced changes in cortical dopamine in the rat

Pharmacology, Biochemistry, and Behavior
A A Hegarty, W H Vogel

Abstract

The mesocortical dopamine system is thought to play an important role in the etiology of the stress response. Dopamine (DA) has been shown to accumulate in the rat frontal cortex in response to a wide variety of stressors. Diazepam, an anxiolytic benzodiazepine, can reverse the effects of stress on cortical DA. We investigated the effects of acute and chronic diazepam administration on immobilization stress-induced changes of the DA system in the frontal cortex of the rat. In the first study, 2.5 mg/kg diazepam was administered 20 min prior to 40 min of immobilization stress. Acute diazepam significantly reduced basal levels of extracellular DA and antagonized the stress-induced increase in cortical DA when compared to untreated stressed rats. Acute diazepam did not significantly effect extracellular DOPAC. In the second study, an experimental group of rats was given approximately 2 mg/kg/day diazepam in their drinking water for 3 weeks. This treatment significantly reduced anxiety as assessed by a staircase test for anxiety. Chronic diazepam had no effect on basal levels of cortical DA. However, chronic diazepam treatment also attenuated stress-induced increases in extracellular DA when compared to untreated stressed control r...Continue Reading

References

Aug 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·A H TissariG L Gessa
Sep 16, 1976·Nature·A M ThierryJ Glowinski
Jan 1, 1990·Progress in Neurobiology·H Benveniste, P C Hüttemeier
Sep 1, 1990·Journal of Neuroscience Methods·G W ArbuthnottS P Butcher
Dec 29, 1986·Life Sciences·L HernandezB G Hoebel
Jun 1, 1989·Pharmacology, Biochemistry, and Behavior·Y IdaM Tanaka
Jan 1, 1988·Annals of the New York Academy of Sciences·D PickarJ Kelsoe
Feb 1, 1986·Pharmacology, Biochemistry, and Behavior·S HjorthA Carlsson
Jan 1, 1988·Annals of the New York Academy of Sciences·R A Wise
Feb 1, 1987·Neuropharmacology·B CostallR J Naylor
Jun 4, 1971·Brain Research·H CorrodiL Olson
Jan 13, 1984·European Journal of Pharmacology·T Zetterström, U Ungerstedt
Apr 1, 1984·Pharmacology, Biochemistry, and Behavior·C Méthot, R Deutsch
Jul 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·P PolcW Haefely
Jun 1, 1993·Pharmacology, Biochemistry, and Behavior·A A Hegarty, W H Vogel

❮ Previous
Next ❯

Citations

Sep 6, 2000·Pharmacology, Biochemistry, and Behavior·J W SloanJ R Holtman
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·J M FaheyD J Greenblatt
May 29, 2002·Archives of Medical Research·Paavo Pokk, Marika Väli
Aug 22, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Pokk, M Väli
May 1, 1997·Psychoneuroendocrinology·N E Goeders
Feb 28, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·D Bentué-FerrerM Bourin
Oct 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·L DazziG Biggio
Apr 27, 2012·Advances in Pharmacological Sciences·Christiaan H Vinkers, Berend Olivier
Dec 24, 2011·Behavioural Brain Research·Lieve DesbonnetColm M P O'Tuathaigh
Apr 12, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Laura DazziGiovanni Biggio
Oct 22, 2017·The Journal of Pharmacology and Experimental Therapeutics·Scott A SchelpErik B Oleson
Aug 16, 2017·World Journal of Gastroenterology : WJG·Ali SalaritabarAnupam Bishayee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.